Novartis may include remote monitoring component with soon-to-be blockbuster heart failure drug.
A new digital health groups aims to further develop pharma apps
March is here, and that means nicer weather along with March Madness! Because we know you have busy lives (along with a lot of basketball to watch) we have condensed for you our top, favorite posts of March thus far. For this installment, we discuss everything from the new iPad to ways you can take an idea for a healthcare app and turn it into a reality. We also look at ways social media is influencing various aspects of patient care.
[We are pleased to present this guest article by Dr. McMenamin, who was a practicing emergency physician before turning his sights to the practice of law. He is currently a partner at McGuireWoods LLP specializing in health-related litigation.] By: Joseph McMenamin, MD, JD Before a pharmaceutical company may lawfully sell a new drug in the […]
Covered by iMA nearly a month ago, the New York Times takes the issue of pharma influence in mobile apps mainstream.
The medical app industry is a big business, but the apps are no longer the product – the physicians, nurses, and other healthcare providers who use them are. In the first part of this series, we examined some of the financial forces driving the medical app industry. Our focus then was Epocrates, the veritable founder […]